ADMA Biologics, Inc.
NASDAQ: ADMA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Adam S. Grossman
- Employees
- 685
- Headquarters
- Ramsey, United States
- IPO year
- 2013
- Market cap
- $2.0B
- Website
- https://www.admabiologics.com
Loading ADMA…
Loading profile data…Frequently asked questions about ADMA
What does ADMA Biologics, Inc. (ADMA) do?
ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and intern...
Where does ADMA trade?
ADMA Biologics, Inc. (ADMA) trades on the NASDAQ Global Market.
What sector is ADMA in?
ADMA Biologics, Inc. (ADMA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ADMA Biologics, Inc.?
Adam S. Grossman is the chief executive officer of ADMA Biologics, Inc. (ADMA).
Where is ADMA Biologics, Inc. headquartered?
ADMA Biologics, Inc. is headquartered in United States.
Does ADMA pay a dividend?
ADMA Biologics, Inc. (ADMA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADMA go public?
ADMA Biologics, Inc. (ADMA) completed its initial public offering in 2013.